Japanese brewery claims antibody works against bird flu

A Japanese brewery says its U.S. subsidiary has developed an antibody that may be effective against bird flu.

Kirin, Japan's second-largest brewer says its subsidiary, Gemini Science Inc., is planning to develop a drug through a partnership.

But according to a company spokesman, it could take as long as two or three years to commercialize any such product.

The H5N1 strain of avian influenza has killed 71 people since late 2003, spreading through flocks of poultry across Asia and into Europe.

One result is that anti-bird flu measures are a closely watched topic in the stock market.

Last week textile maker Nisshinbo Industries Inc. shares surged after the company announced a partnership with a Japanese university had jointly developed a new fabric that destroys the bird flu virus.

The company claims the product can be used for masks and clothing as well as for materials for chicken coops.

Interestingly Kirin Brewery shares also rose 7.1 percent to 1,412 yen after earlier climbing as high as to 1,471 yen, a level last seen in 1999.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
As California taps pandemic stockpile for bird flu, officials keep close eye on spending